Navigation Links
Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
Date:2/24/2009

KANSAS CITY, Mo., Feb. 24 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products, has petitioned the Office of the Director of Corporate Enforcement to facilitate compliance with key company law provisions designed to permit communication between shareholders and prospective shareholders.

The petition as filed asserts that Irish-based independent directors, Peter Coyne of Allied Irish Bank, and Dr. Jim Walsh, together with Chairman and CEO, Ronan O'Caoimh have breached Irish Company Law by blocking access to information requested by shareholders wishing to convert ADRs (American Depository Receipts) to the Irish shares they represent. The investor group has requested ODCE support of a formal investigation of the above named individuals for violation of Company Law and to pursue corrective action against this illegal behavior.

Commenting on the news, Mr. Reidy stated, "We are disappointed that the current Board has disregarded not only the wishes of shareholders but its obligations to respond to shareholder requests for the calling of an EGM (Extraordinary General Meeting). We are particularly displeased by the board's refusal to provide periodic notification of changes in registered ownership of company shares, which we view as a basic right protected under Irish securities law."

Contact: Tom Reidy, 816-260-8476, tjreidy3@hotmail.com


'/>"/>
SOURCE KC Investor Group
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related biology technology :

1. Adolor Corporation to Host Investor Conference Call to Report 2008 Financials and Provide an Update on the Launch of ENTEREG(R) (alvimopan)
2. Famed IT Investor and Director of 23andme Esther Dyson Identifies on IdeasProject.com Genetic Information as an Extremely Disruptive Force
3. BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors
4. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
5. Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference
6. In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors
7. BioMS Medical to present at BIO CEO and Investor Conference
8. Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009
9. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
10. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
11. Sunesis to Present at the 11th Annual BIO CEO & Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Calif., Dec. 2 Peregri...ported completion of patient enrollment in a dose ...n patients with relapsed glioblastoma multiforme (...is a targeted monoclonal antibody linked to a radi...ent for GBM. Cotara specifically targets cells at...
(Date:12/2/2009)...EVILLE, Gabon, December 2 , ...s Problem and Heritage" , Coinciding with...2010 the,Gabonese Republic is hosting an internati... of safeguarding biological resources in Africa. T...tate leaders, ministers,scientific experts, priva...
(Date:12/2/2009)...BRIDGE, Mass., Dec. 2 TechConnect ...echnology development and product integration in c...e December 11th deadline for technology abstracts ...year, TechConnect World, in association with the N...he Clean Technology and Sustainable Industries Org...
(Date:12/2/2009)...GAPORE, Dec. 2 S*BIO Pte Ltd today...K2 inhibitor, SB1518, at The American Society of H...w Orleans. ,, Data will be presented on the cli...al of SB1518 detailing its safety, tolerability an...in dose levels ranging from 100 to 600 mg. These d...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...d in Indonesia, Thailand and Sri Lanka when the ch...lled the wealthier nations of the world stingy for...d off the remark as yet another reason to dislike ...have done, anyway: They opened their hearts and wa...able outpouring of private and corporate relief f...
...VoIP, may have found the missing link that would e...e a lot of telephone companies go into a state of ...paralyzed. , ,The telcos and cable companies are b...sue of delivering voice over the Internet and to b...evices. This enables them to provide the end-user ...
...ve Ophir Creek in Alaska. Credit: Alaska Division ... rural Alaskan knowledge can now spread globally t...nmental Remote Sensing Center and the Alaska Divis...MapTeach effort, or Mapping Technology Experience...combine geospatial information with traditional kn...
Other Biology Technology:Are we stingy on tsunami relief? Not when private giving is counted 2Are we stingy on tsunami relief? Not when private giving is counted 3The day the old telephony died 2The day the old telephony died 3MapTeach project spreads Alaskan geographic knowledge online 2MapTeach project spreads Alaskan geographic knowledge online 3
(Date:12/2/2009)...s of carbon about a nanometer in diameterhave been...ultrastrong fibers, electrical wires in molecular ...ells. Thanks to a new development by researchers a...gy (NIST) and five partners, you can add one more ... of an aggressive form of breast cancer. , HER2 ...
(Date:12/2/2009)...cording to the National Institute of Health, 40 pe...abetes already have some stage of diabetic retinop...caused by leaky blood vessels, is a major cause of...he most feared diabetic complications. In fact, u...s for 10 years or more will experience some form o...
(Date:12/1/2009)...Dec. 1 GestureTek Inc. today annou...ey, portable, plug and play interactive projection...inment and touring promotions. GestureTek is the i...enabled gesture recognition technology for interac...ms. ,, Guaranteed for quality, the CUBE has TUV...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 1Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 3Regeneron Announces September 2009 Investment Conference Presentations 56871 1Regeneron Announces September 2009 Investment Conference Presentations 56871 2BayCare Outpatient Center Opens in Westchase Florida 56869 1
...researchers have used an experimental therapy in m...in a leading cause of inherited blindness. , The t...Research, involves injecting the eye with a bit of...lps disable the gene. , Normally the gene is es... of it are passed from generation to generation in...
...out of Africa some 60,000 years ago to populate th...he bacterium Helicobacter pylori, which causes gas... bacterium spread throughout the entire world. Thi...am of scientists led by Mark Achtman from the Max ...Germany. The researchers also discovered that diff...
... but they keep growing because they don,t react to...ers at Washington University School of Medicine in...ssenger into cancer cells that forces them to resp... the most sinister pathogens around ?HIV. , "HIV k...s of cells," says senior author William G. Hawkins...
Other Biology News:Gene therapy for blindness clears hurdle in mice 2Out of Africa -- Bacteria, as well 2HIV protein enlisted to help kill cancer cells 2HIV protein enlisted to help kill cancer cells 3
...ning CellBIND surface is produced by a patented mi...face giving more consistent, even cell attachment,...es cell attachment and growth uunder difficult con...ium. • CellBIND may provide a more ecominic a...
...-Plex suspension array system, 100-240 V, uses xMA...s of up to 100 proteins and peptides in one microp...to 100 color-coded bead sets, each of which may be...tes, receptors, antigens, or antibodies) specific ...
FACTS from Tecan
...ually every research laboratory, the revolutionary...on accurately, inexpensively and in real time enha...compact lab analysis system includes the Luminex 1...technology which enables you to simultaneously ass...
Biology Products: